Novavax (NVAX) Interest Coverage Ratio (2010 - 2026)
Novavax's (NVAX) quarterly Interest Coverage Ratio came in at 2.45 in Q1 2026, down 102.72% year-on-year from 90.08 in Q1 2025, and down 279.76% quarter-over-quarter from 1.36 in Q4 2025.
Novavax (NVAX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Novavax's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 2.45 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 102.72% year-over-year to 2.45 in Q1 2026; TTM through Mar 2026 was 2.79, a 147.05% decrease from a year earlier, with the FY2025 full-year figure at 0.44, up 301.37% from the prior year.
- Interest Coverage Ratio eased to 2.45 in Q1 2026 per NVAX's latest filing, from 1.36 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 90.08 in Q1 2025 and bottomed at 77.47 in Q2 2022.
- The 5-year median for Interest Coverage Ratio is 2.45 (2026), against an average of 7.72.
- Across the five-year window, Interest Coverage Ratio slumped 2279.03% in 2023 and soared 355.68% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1.39 in 2022, then slumped by 2279.03% to 33.18 in 2023, then jumped by 92.84% to 2.38 in 2024, then surged by 157.4% to 1.36 in 2025, then plunged by 279.76% to 2.45 in 2026.
- Per Business Quant, the three latest NVAX Interest Coverage Ratio figures stand at 2.45 (Q1 2026), 1.36 (Q4 2025), and 23.27 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -2.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 |
| Dec 31, 2025 | 1.36 |
| Sep 30, 2025 | -23.27 |
| Jun 30, 2025 | 18.32 |
| Mar 31, 2025 | 90.08 |
| Dec 31, 2024 | -2.38 |
| Sep 30, 2024 | -31.64 |
| Jun 30, 2024 | 38.86 |
| Mar 31, 2024 | -35.23 |
| Dec 31, 2023 | -33.18 |
| Sep 30, 2023 | -43.94 |
| Jun 30, 2023 | 17.75 |
| Mar 31, 2023 | -47.63 |
| Dec 31, 2022 | -1.39 |
| Sep 30, 2022 | -30.51 |
| Jun 30, 2022 | -77.47 |
| Mar 31, 2022 | 31.45 |
| Dec 31, 2021 | -4.39 |
| Sep 30, 2021 | -59.27 |
| Jun 30, 2021 | -57.95 |